Profile
APDN DHR-PB TMO DHR IDXX A
Company Name Applied DNA Sciences, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $7.26M $916.76B $203.95B $153.12B $55.48B $36.74B
Employees 0.05K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO James A. Hayward Sc.D. Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
APDN DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
APDN DHR-PB TMO DHR IDXX A
Last Close $5.62 $1261.26 $567.16 $220.44 $669 $144.52
High 52 $6 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $0.05 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -6.33 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low 11140 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
APDN DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return 42.82 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return 738.81 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return 3255.22 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return 2654.9 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return 3289.63 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APDN DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.59 % 0.32 % 0.59 % - 0.77 %
Dividend Paid and Capex Coverage Ration (TTM) -18.38 % 3.15 % 3.62 % 3.15 % 8.09 % 2.26 %
Dividend Per Share (TTM) - 1.28 % 1.72 % 1.28 % - 1 %
Payout Ratio (TTM) - 24.29 % 9.47 % 24.29 % - 21.64 %
Growth
APDN DHR-PB TMO DHR IDXX A
Asset Growth -65.3 % 7.64 % 13.38 % 7.64 % 1.03 %
Gross Profit Growth -17.5 % 5.38 % -5.36 % 5.38 % 8.63 %
Revenue Growth -37.72 % 2.9 % 3.91 % 2.9 % 6.46 %
Revenue 3 Year -89.81 % -5.47 % 3.42 % -5.47 % 25.23 %
Revenue 5 Year -58.12 % 10.08 % 45.65 % 10.08 % 69.09 %
Revenue 10 Year -98.92 % 68 % 178.48 % 68 % 218.38 %
EBIT Growth 100 % -7.15 % -6.71 % -7.15 % 3.47 %
Net Income Growth -893.74 % -7.31 % 6.35 % -7.31 % 5.07 %
Net Income 3 Yeari Growth Per Share -618.4 % -48.61 % 1.06 % -48.61 % 23.15 %
Net Income 5 Yeari Growth Per Share -106.06 % -1.03 % 11.3 % -1.03 % 116.76 %
Net Income 10 Yeari Growth Per Share 73.25 % 37.36 % 261.63 % 37.36 % 492.42 %
Operating Income Growth -14.42 % -0.91 % 5.83 % -0.91 % 2.84 %
Operating Cash Flow Growth (CFG) 10.71 % -4.07 % -9.8 % -4.07 % 2.48 %
Operating 3 Year CFG -18.13 % -22.79 % -10.96 % -22.79 % 27.03 %
Operating 5 Year CFG 58.41 % 3.19 % -0.67 % 3.19 % 111.28 %
Operating 10 Year CFG 91.96 % 66.57 % 194.29 % 66.57 % 378.1 %
EPS Growth -7275.27 % -4.88 % 7.18 % -4.88 % 5.9 %
EPS Diluted Growth -7275.27 % -4.73 % 7.32 % -4.73 % 6.06 %
Book Value Per Share 65.88 % 9.57 % 9.5 % 9.57 % 8.24 %
Share Holder 3 Year Equity Growth Per Share -86.97 % 7.54 % 26.63 % 7.54 % 138.87 %
Share Holder 5 Year Equity Growth Per Share -87.15 % 31.9 % 63.03 % 31.9 % 838.67 %
Share Holder 10 Year Equity Growth Per Share -99.29 % 118.87 % 165.29 % 118.87 % 1547.69 %
Dividend Per Share Growth 178465.91 % 18.15 % 10.83 % 18.15 % -
Dividend 3 Year Growth Per Share 42637.1 % 10.04 % 45.73 % 10.04 % -
Dividend 5 Year Growth Per Share - 42.54 % 98.76 % 42.54 % -
Dividend 10 Year Growth Per Share - 144.73 % 180.3 % 144.73 % -
Debt Growth -73.86 % 7.42 % 20.17 % 7.42 % -7.53 %
Free Cash Flow Growth 11.07 % -0.68 % -13.4 % -0.68 % 3.26 %
Updated On 30 Sep 2025 31 Dec 2025 31 Dec 2025 31 Dec 2025 31 Dec 2024
Profitability
APDN DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 39.58 % 60.93 % 39.46 % 60.93 % 61.72 % 52.43 %
Return on Assets TTM -132.72 % 4.33 % 6.09 % 4.33 % 30.34 % 10.24 %
Return on Equity TTM -133.13 % 6.99 % 13.14 % 6.99 % 67.78 % 20.62 %
Return on Capital Employed TTM -169.53 % 6.7 % 8.41 % 6.7 % 61.18 % 14.25 %
Net Income Per EBT TTM 101.69 % 85.38 % 92.39 % 85.38 % 80.67 % 90.8 %
EBT Per Ebit TTM 96.83 % 82.4 % 90.83 % 82.4 % 97.51 % 97.03 %
EBIT Per Revenue TTM -406.1 % 20.91 % 17.96 % 20.91 % 31.34 % 21.29 %
Cash Flow To Debt Ratio TTM -3760.86 % 34.84 % 19.85 % 34.84 % 97.76 % 46.48 %
Receivables Turnover TTM 16.57 6.28 5.01 6.28 5.83 4.67
Payables Turnover TTM 3.24 5.2 - 5.2 13.05 5.8
Inventory Turnover TTM 5.88 3.86 4.97 3.86 4.07 3.22
Fixed Asset Turnover TTM 389.96 % 444.19 % 421.73 % 444.19 % 480.31 % 343.45 %
Asset Turnover TTM 33.19 % 29.44 % 40.38 % 29.44 % 123.05 % 54.59 %
Operating Cash Flow Per Share TTM -21.99 9.07 20.79 9.07 13.58 5.51
Free Cash Flow Per Share TTM -23.18 7.44 16.74 7.44 11.91 4.07
Cash Per Share TTM 826.49 % 652.48 % 2687.5 % 652.48 % 259.9 % 632.16 %
Operating Cash Flow Sales Ratio TTM -381.39 % 26.12 % 17.55 % 26.12 % 26.11 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.44 % 81.98 % 80.49 % 81.98 % 87.64 % 73.89 %
Cash Flow Coverage Ratios TTM -3760.86 % 34.84 % 19.85 % 34.84 % 97.76 % 46.48 %
Price To Free Cash Flows Ratio TTM -0.13 29.11 32.41 29.11 58.18 31.89
Price To Operating Cash Flows Ratio TTM -0.06 23.88 26.11 23.88 51.14 23.52
Price Cash Flow Ratio TTM -0.06 23.88 26.11 23.88 51.14 23.52
Income Statement (TTM)
APDN DHR-PB TMO DHR IDXX A
Revenue $0B $24.57B $44.56B $24.57B $4.3B $6.95B
Gross Profit $0B $14.97B $16.78B $14.97B $2.66B $3.64B
Gross Profit Ratio 39.26% 60.93% 37.66% 60.93% 61.8% 52.43%
EBITDA $-0.02B $6.95B $10.89B $6.95B $1.47B $1.84B
Net Income $-0.07B $3.61B $6.74B $3.61B $1.06B $1.3B
EPS Diluted -134.23 5.04 17.74 5.04 13.08 4.57
Balance Sheet (MRQ)
APDN DHR-PB TMO DHR IDXX A
Long Term Debt $0B $18.42B $35.85B $18.42B $0.37B $3.05B
Total Liabilities $0B $30.93B $56.81B $30.93B $1.75B $5.99B
Total Equity $0B $52.54B $53.54B $52.54B $1.61B $6.74B
Total Investments $0B $0B $0.25B $0B $0B $0.13B
Total Debt $0B $18.42B $39.39B $18.42B $0.85B $3.35B
Total Assets $0B $83.46B $110.34B $83.46B $3.35B $12.73B
Cash Flow Statement (TTM)
APDN DHR-PB TMO DHR IDXX A
Net Income $-0.02B $3.61B $6.72B $3.61B $1.06B $0.43B
Inventory $0B $-0.06B $0B $-0.06B $0B $0.05B
Dividends Paid $-0.05B $-0.88B $-0.64B $-0.88B $0B $-0.28B
Operating Cash Flow $-0.01B $6.42B $7.82B $6.42B $1.18B $1.56B
Capital Expenditure $-0B $-1.16B $-1.53B $-1.16B $-0.12B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 129.58
ACRS Aclaris Therapeutics, Inc. 3.57
ADVB Advanced Biomed Inc. Common Stock 0.2319
AKU Akumin Inc. 0.2887
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 10.38
BIAF bioAffinity Technologies, Inc. 0.8512
BIAFW bioAffinity Technologies, Inc. 0.2204
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 90.61
BNGO Bionano Genomics, Inc. 1.15
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 34
CDNA CareDx, Inc 19.47
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.68
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 189.21
CSTL Castle Biosciences, Inc. 32.75
ETFs With Exposure to APDN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 340.96
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.14
VXF Vanguard Extended Market Index Fund 0 217.96
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000062 41.29
VTSAX Vanguard Total Stock Market Index Fund 0 166.03
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.43
VITSX Vanguard Total Stock Market Index Fund 0 166.06
DFSU Dimensional US Sustainability Core 1 ETF 0.00009711 44.295
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.44
VEMPX Vanguard Extended Market Index InstlPlus 0 408.25
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 311.51
Unlock